US Patent Issued to Vessi Therapeutics on Aug. 4 for "Methods of preconditioning vascular cells for transduction, methods of transduction and methods of preserving transduced cells" (Israeli Inventor)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,477, issued on Aug. 4, was assigned to Vessi Therapeutics Ltd (Haifa, Israel).

"Methods of preconditioning vascular cells for transduction, methods of transduction and methods of preserving transduced cells" was invented by Moshe Y. Flugelman (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for pre-conditioning, transduction and/or hypothermic preservation of vascular cells transduced with nucleic acid constructs for expressing pro-angiogenic factors are provided. Also provided are uses of such cells in therapy."

The patent was filed on Nov. 10, 2021, under Application No. 17/523,041.

*For further information, ...